Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

compresie spinală, iradiere sau chirurgie osoasă sau

hipercalcemie indusă de tumori) la pacienţi cu tumori

maligne avansate, cu implicare osoasă.

Tratamentul hipercalcemiei induse de tumori.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

M05BA08 ACIDUM ZOLEDRONICUM PULB. + SOLV. SOL. 4 mg

PERF.

ZOMETA 4 mg 4 mg NOVARTIS EUROPHARM LTD.

M05BA08 ACIDUM ZOLEDRONICUM SOL. PERF. 5 mg/100 ml

ACLASTA 5 mg/100 ml 5 mg/100 ml NOVARTIS EUROPHARM LTD.

________________________________________________________________________________
______________________________________________________________________________

| 781 |V03AF01| MESNUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

V03AF01 MESNUM SOL. INJ. 400 mg/4 ml

UROMITEXAN(R) 400 mg 400 mg/4 ml BAXTER ONCOLOGY GMBH

________________________________________________________________________________

______________________________________________________________________________

| 782 |V03AF03| CALCII FOLINAS | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

V03AF03 CALCII FOLINAS SOL. INJ. 10 mg/ml

FOLCASIN 10 mg/ml 10 mg/ml ACTAVIS S.R.L.

FOLCASIN(R) 100 mg/10 ml 10 mg/ml ACTAVIS S.R.L.

LEUCOVORIN-TEVA 100 mg/10 ml 10 mg/ml TEVA PHARM. IND. LTD.

LEUCOVORIN-TEVA 50 mg/5 ml 10 mg/ml TEVA PHARMACEUTICALS

S.R.L.
V03AF03 CALCII FOLINAS SOL. INJ. 10 mg/ml

FOLCASIN 10 mg/ml 10 mg/ml ACTAVIS S.R.L.

FOLCASIN(R) 100 mg/10 ml 10 mg/ml ACTAVIS S.R.L.

LEUCOVORIN-TEVA 100 mg/10 ml 10 mg/ml TEVA PHARM. IND. LTD.

LEUCOVORIN-TEVA 50 mg/5 ml 10 mg/ml TEVA PHARMACEUTICALS

S.R.L.
V03AF03 CALCII FOLINAS SOL. INJ./PERF. 10 mg/ml

CALCIUMFOLINAT 10 mg/ml EBEWE PHARMA GMBH NFG. KG

"EBEWE" 10 mg/ml

V03AF03 CALCII FOLINAS CAPS. 15 mg

CALCIUM FOLINAT 15 mg EBEWE PHARMA GES.M.B.H.

"EBEWE" 15 mg NFG KG
V03AF03 CALCII FOLINAS SOL. INJ. 3 mg/ml

FOLCASIN(R) 30 mg/10 ml 3 mg/ml ACTAVIS S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 783 |V03AF05| AMIFOSTINUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

V03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF. 375 mg

ETHYOL 375 mg SCHERING PLOUGH EUROPE
V03AF05 AMIFOSTINUM LIOF. PT. SOL. PERF. 500 mg

ETHYOL(R) 500 mg SCHERING PLOUGH EUROPE

________________________________________________________________________________
SUBLISTA C2 - P4: PROGRAMUL NAŢIONAL DE BOLI NEUROLOGICE. SUBPROGRAMUL DE TRATAMENT AL SCLEROZEI MULTIPLE